Literature DB >> 16687933

Human polynucleotide phosphorylase (hPNPase old-35): an RNA degradation enzyme with pleiotrophic biological effects.

Devanand Sarkar1, Paul B Fisher.   

Abstract

Identification of small inhibitory RNAs and microRNA established that regulation of RNA metabolism plays an essential role in controlling intracellular biochemical processes. Interferons induce a number of RNA degradation enzymes involved in innate immunity by degrading viral RNAs. We cloned human polynucleotide phosphorylase (hPNPase(old-35)), a type I interferon-inducible 3'-5' exoribonuclease, as a transcript induced during terminal differentiation and senescence, two physiological processes marked by irreversible growth arrest. Our studies in the last four years show that hPNPase(old-35) plays an essential role in mediating IFN-mediated growth inhibition and its upregulation might mediate chronic inflammatory pathological processes during aging. The present review recaps these findings and provides a framework for the future understanding of the versatile functions of this interesting molecule.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16687933     DOI: 10.4161/cc.5.10.2741

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  11 in total

Review 1.  The 2',3'-cAMP-adenosine pathway.

Authors:  Edwin K Jackson
Journal:  Am J Physiol Renal Physiol       Date:  2011-09-21

Review 2.  Pathways of oncogene-induced senescence in human melanocytic cells.

Authors:  Rajat Bansal; Mikhail A Nikiforov
Journal:  Cell Cycle       Date:  2010-07-03       Impact factor: 4.534

Review 3.  RNA recognition by 3'-to-5' exonucleases: the substrate perspective.

Authors:  Hend Ibrahim; Jeffrey Wilusz; Carol J Wilusz
Journal:  Biochim Biophys Acta       Date:  2007-12-03

4.  Age-associated declines in mitochondrial biogenesis and protein quality control factors are minimized by exercise training.

Authors:  Erika Koltai; Nikolett Hart; Albert W Taylor; Sataro Goto; Jenny K Ngo; Kelvin J A Davies; Zsolt Radak
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-05-09       Impact factor: 3.619

5.  Uncoupling the roles of the SUV3 helicase in maintenance of mitochondrial genome stability and RNA degradation.

Authors:  Xuning Emily Guo; Chi-Fen Chen; Dennis Ding-Hwa Wang; Aram Sandaldjian Modrek; Vy Hoai Phan; Wen-Hwa Lee; Phang-Lang Chen
Journal:  J Biol Chem       Date:  2011-09-12       Impact factor: 5.157

6.  Integration of chloroplast nucleic acid metabolism into the phosphate deprivation response in Chlamydomonas reinhardtii.

Authors:  Shlomit Yehudai-Resheff; Sara L Zimmer; Yutaka Komine; David B Stern
Journal:  Plant Cell       Date:  2007-03-09       Impact factor: 11.277

7.  Epigenetic modulation of β cells by interferon-α via PNPT1/mir-26a/TET2 triggers autoimmune diabetes.

Authors:  Mihaela Stefan-Lifshitz; Esra Karakose; Lingguang Cui; Abora Ettela; Zhengzi Yi; Weijia Zhang; Yaron Tomer
Journal:  JCI Insight       Date:  2019-03-07

8.  Helicase SUV3, polynucleotide phosphorylase, and mitochondrial polyadenylation polymerase form a transient complex to modulate mitochondrial mRNA polyadenylated tail lengths in response to energetic changes.

Authors:  Dennis Ding-Hwa Wang; Xuning Emily Guo; Aram Sandaldjian Modrek; Chi-Fen Chen; Phang-Lang Chen; Wen-Hwa Lee
Journal:  J Biol Chem       Date:  2014-04-25       Impact factor: 5.157

9.  Analysis of global changes in gene expression induced by human polynucleotide phosphorylase (hPNPase(old-35)).

Authors:  Upneet K Sokhi; Manny D Bacolod; Luni Emdad; Swadesh K Das; Catherine I Dumur; Michael F Miles; Devanand Sarkar; Paul B Fisher
Journal:  J Cell Physiol       Date:  2014-12       Impact factor: 6.384

10.  Identification of genes potentially regulated by human polynucleotide phosphorylase (hPNPase old-35) using melanoma as a model.

Authors:  Upneet K Sokhi; Manny D Bacolod; Santanu Dasgupta; Luni Emdad; Swadesh K Das; Catherine I Dumur; Michael F Miles; Devanand Sarkar; Paul B Fisher
Journal:  PLoS One       Date:  2013-10-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.